This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Health Care

Health Care

Company Last %CHNG Volume
Response Genetics Inc (RGDX) 0.27 -38.64 0.46 M
Cytosorbents Corp (CTSO) 9.02 -31.61 2.30 M
Achaogen Inc (AKAO) 8.00 -18.03 0.79 M
Akebia Therapeutics Inc (AKBA) 9.51 -14.40 0.27 M
Oragenics Inc (OGEN) 0.88 -14.12 0.02 M
Egalet Corp (EGLT) 11.44 -11.52 0.62 M
Coherus BioSciences Inc (CHRS) 27.28 -10.79 2.50 M
Cerulean Pharma Inc (CERU) 8.05 -10.65 0.13 M
Celladon Corp (CLDN) 16.97 -10.40 2.51 M
OvaScience Inc (OVAS) 31.15 -10.31 2.06 M
Company Last %CHNG Mkt Cap
Johnson & Johnson (JNJ) 99.15 -1.44 $282.4 B
Novartis AG (NVS) 99.86 1.27 $243.0 B
Pfizer Inc (PFE) 34.33 -1.32 $214.9 B
Merck & Co Inc (MRK) 56.86 -1.08 $165.6 B
Gilead Sciences Inc (GILD) 97.72 -0.42 $149.3 B
Novo Nordisk A/S (NVO) 54.63 2.32 $144.9 B
Sanofi (SNY) 49.93 0.99 $132.6 B
GlaxoSmithKline PLC (GSK) 46.69 1.17 $126.4 B
Amgen Inc (AMGN) 157.10 -1.72 $124.7 B
CVS Health Corp (CVS) 102.26 -0.92 $117.9 B

Featured Industry: Transportation

  1. Cadillac's CT6 Is Flagship of Luxury Brand's $12 Billion Makeover

    Cadillac's CT6 Is Flagship of Luxury Brand's $12 Billion Makeover

    Cadillac's new CT6 sedan, introduced this week at the New York Auto Show, takes the 113-year-old brand back into the market where people expect it to be, its president says.

    American Airlines Leads Aviation Sector Lower on Oil Rebound

    GM Focused on Quality, Unveils Nine New Cars at New York Auto Show

    Will CarMax Shares Hit the Skids After Earnings Report?

    Sears Pops on REIT Plans as Stocks Effort to Recover From Their Lows

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs